Axsome Therapeutics, Inc. (AXSM) has 24 open-market insider trades by 8 insiders since 2015. The most active filer is Mark Coleman, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Herriot Tabuteau | CEO10% Owner | — | 1 | $23.9M | 2026-08-06 |
| Mark L. Jacobson | COO | — | 2 | $6.9M | 2026-09-03 |
| Mark E. Saad | Dir | — | 3 | $6.4M | 2026-06-08 |
| Nick Pizzie | CFO | — | 7 | $2.7M | 2026-06-09 |
| Ari Maizel | CCO | — | 1 | $1.4M | 2026-04-22 |
| Mark Coleman | Dir | — | 8 | $1.3M | 2026-06-10 |
| Roger Jeffs | Dir | — | 1 | $147K | 2026-06-11 |
| Randall Kaye | Chief Medical Officer | — | 1 | $9K | 2015-12-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark L. Jacobson | COO | Sell | $2.1M | 2026-09-03 |
| Herriot Tabuteau | CEO & 10% Owner | Sell | $10.5M | 2026-08-05 |
| Herriot Tabuteau | CEO & 10% Owner | Sell | $11.9M | 2026-07-01 |
| Mark Coleman | Director | Sell | $160K | 2026-06-10 |
| Roger Jeffs | Director | Sell | $142K | 2026-06-10 |
| Herriot Tabuteau | CEO & 10% Owner | Sell | $12.0M |
Companies that share insiders with AXSM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-06-09 |
| Nick Pizzie | CFO | Sell | $7.9M | 2026-06-09 |
| Susan Mahony | Director | Sell | $145K | 2026-06-09 |
| Mark Coleman | Director | Sell | $4.0M | 2026-05-29 |
| Mark L. Jacobson | COO | Sell | $1.1M | 2026-05-04 |
| Ari Maizel | CCO | Sell | $1.4M | 2026-04-22 |
| Mark L. Jacobson | COO | Sell | $5.7M | 2026-02-26 |
| Mark Coleman | Director | Sell | $4.0M | 2026-02-26 |
| Herriot Tabuteau | CEO & 10% | Sell | $6.0M | 2026-02-02 |
| Nick Pizzie | CFO | Sell | $2.3M | 2026-01-22 |